BBOT
NASDAQ · Biotechnology
Bridgebio Oncology Therapeut
$7.32
-0.18 (-2.40%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+488.8% upside
Low Target
$22.76
Average Target
$43.10
High Target
$48.38
Current Price
$7.32
Current
$7.32
$7.32
Target
$43.10
$43.10
$22.76
$43.10 avg
$48.38
Scenario Analysis
Bear Case
$22.76
210.9%
Low target
Base Case
$43.10
+488.8%
Avg target
Bull Case
$48.38
+560.9%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$14.87
-50.8% from high
52-Week Low
$7.00
+4.6% from low
Target vs 52W High
$43.10
+189.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.6% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.9% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +188.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -8.5% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -65.9% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -45.4% |